Effects of Tranilast and Pentoxifylline in a Mouse Model of Chronic Asthma Using House Dust Mite Antigen

References

• Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol 2005; 116:477–486; quiz 487.
   PubMed Web of Science ®Google Scholar
• Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323:502–507.
   PubMed Web of Science ®Google Scholar
• Arlian LG, Platts-Mills TA. The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol 2001; 107:S406–413.
   PubMed Web of Science ®Google Scholar
• Azuma H, Banno K, Yoshimura T. Pharmacological properties of N-(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. Br J Pharmacol 1976; 58:483–488.
   PubMed Web of Science ®Google Scholar
• Zampini P, Riviera AP, Tridente G. In vitro inhibition of histamine release from mouse mast cells and human basophils by an anthranilic acid derivative. Int J Immunopharmacol 1983; 5:431–435.
   PubMed Web of Science ®Google Scholar
• Koda A, Kurashina Y, Nakazawa M. The inhibition mechanism of histamine release by N-(3,4-dimethoxycinnamoyl) anthranilic acid. Int Arch Allergy Appl Immunol 1985; 77:244–245.
   PubMedGoogle Scholar
• Nishigaki T. Mast cell degranulation and its inhibition by an anti-allergic agent tranilast. An electron microscopic study. Virchows Arch B Cell Pathol Incl Mol Pathol 1988; 55:311–322.
   PubMedGoogle Scholar
• Isaji M, Nakajoh M, Naito J. Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5') in granulation tissue. Biochem Pharmacol 1987; 36:469–474.
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, Ujiie A. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 1995; 118:213–221.
   PubMed Web of Science ®Google Scholar
• Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994; 30:603–621.
   PubMed Web of Science ®Google Scholar
• Rott O, Cash E, Fleischer B. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 1993; 23:1745–1751.
   PubMed Web of Science ®Google Scholar
• Benbernou N, Esnault S, Potron G, Guenounou M. Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells. J Cardiovasc Pharmacol 1995; 25 (suppl 2):S75–79.
   PubMed Web of Science ®Google Scholar
• Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, Karp CL. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 1997; 91:197–203.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Nakamura T, Furuya T, Nakane S, Shirabe S, Kambara C, Hamasaki S, Yoshimura T, Eguchi K. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy. Intern Med 1999; 38:717–721.
   PubMed Web of Science ®Google Scholar
• Fleming CM, He H, Ciota A, Perkins D, Finn PW. Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyperresponsiveness. J Immunol 2001; 167:1703–1711.
   PubMed Web of Science ®Google Scholar
• Padrid P, Snook S, Finucane T, Shiue P, Cozzi P, Solway J, Leff AR. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995; 151:184–193.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Inao M, Fujiwara K. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. Biochem Biophys Res Commun 1996; 227:322–327.
   PubMed Web of Science ®Google Scholar
• Yamada H, Tajima S, Nishikawa T. Tranilast inhibits collagen synthesis in normal, scleroderma and keloid fibroblasts at a late passage culture but not at an early passage culture. J Dermatol Sci 1995; 9:45–47.
   PubMed Web of Science ®Google Scholar
• Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, Krum H, Wilkinson-Berka J, Gilbert RE. Tranilast attenuates cardiac matrix deposition in experimental diabetes: Role of transforming growth factor-beta. Cardiovasc Res 2005; 65:694–701.
   PubMed Web of Science ®Google Scholar
• Qi W, Chen X, Twigg S, Polhill TS, Gilbert RE, Pollock CA. Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 2006; 69:989–995.
   PubMed Web of Science ®Google Scholar
• Oshima T, Kurosaka D, Kato K, Kurosaka H, Mashima Y, Tanaka Y, Tajima S. Tranilast inhibits cell proliferation and collagen synthesis by rabbit corneal and Tenon's capsule fibroblasts. Curr Eye Res 2000; 20:283–286.
   PubMed Web of Science ®Google Scholar
• Gopalan R, Goldberg S. Tranilast in the Therapy of Coronary Artery Disease. Curr Interv Cardiol Rep 2000; 2:149–156.
   PubMedGoogle Scholar
• Soma J, Sato K, Saito H, Tsuchiya Y. Effect of tranilast in early-stage diabetic nephropathy. Nephrol Dial Transplant 2006; 21:2795–2799.
   PubMed Web of Science ®Google Scholar
• Entzian P, Bitter-Suermann S, Burdon D, Ernst M, Schlaak M, Zabel P. Differences in the anti-inflammatory effects of theophylline and pentoxifylline: Important for the development of asthma therapy? Allergy 1998; 53:749–754.
   PubMed Web of Science ®Google Scholar
• Lauterbach R, Pawlik D, Zembala M, Szymura-Oleksiak J, Lisowska-Miszczyk I, Kowalczyk D, Bury J. Pentoxyfylline in and prevention and treatment of chronic lung disease. Acta Paediatr Suppl 2004; 93:20–22.
   PubMedGoogle Scholar
• McGee HS, Agrawal DK. TH2 cells in the pathogenesis of airway remodeling: Regulatory T cells a plausible panacea for asthma. Immunol Res 2006; 35:219–232.
   PubMed Web of Science ®Google Scholar
• Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax 2005; 60:529–530.
   PubMed Web of Science ®Google Scholar
• Peters-Golden M. The alveolar macrophage: The forgotten cell in asthma. Am J Respir Cell Mol Biol 2004; 31:3–7.
   PubMed Web of Science ®Google Scholar
• Entzian P, Zahringer U, Schlaak M, Gerlach C, Galle J, Zabel P. Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis. Int J Immunopharmacol 1998; 20:723–735.
   PubMed Web of Science ®Google Scholar